News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Healthcap IV Is Committed To Vote In Support Of TopoTarget A/S’s Proposed Merger With BioAlliance Pharma


4/29/2014 9:37:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Topotarget has received the following announcement from its major shareholder the HealthCap funds:

The venture capital fund HealthCap IV is committed to vote in support of the proposed merger between the Danish biotech company Topotarget A/S (NASDAQ OMX: TOPO) and the French oncology company BioAlliance Pharma SA (Euronext Paris: BIO), which was announced on April 16, 2014.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES